Cambridge-based Spirea raises $3 million
Cambridge-based biotech company Spirea has raised $3 million to advance a new generation of antibody-drug conjugate (ADC) therapeutics. The round was co-led ...
Cambridge-based biotech company Spirea has raised $3 million to advance a new generation of antibody-drug conjugate (ADC) therapeutics. The round was co-led ...